Catalysts for Janssen Biotech Inc
140 tracked
Feb 8, 2021
approval
DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approval
(daratumumab + hyaluronidase (human recombinant))
→
Jan 15, 2021
approval
DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approval
(daratumumab + hyaluronidase (human recombinant))
→
Jan 11, 2021
approval
DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approval
(daratumumab + hyaluronidase (human recombinant))
→
Dec 11, 2020
approval
STELARA (USTEKINUMAB) — FDA approval
ustekinumab
→
Dec 1, 2020
approval
STELARA (USTEKINUMAB) — FDA approval
ustekinumab
→
Nov 20, 2020
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Sep 1, 2020
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Jul 13, 2020
approval
TREMFYA (GUSELKUMAB) — FDA approval
guselkumab
→
Jul 10, 2020
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Jun 1, 2020
approval
TREMFYA (GUSELKUMAB) — FDA approval
guselkumab
→
May 1, 2020
approval
DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approval
(daratumumab + hyaluronidase (human recombinant))
→
Apr 7, 2020
approval
STELARA (USTEKINUMAB) — FDA approval
ustekinumab
→
Apr 2, 2020
approval
BALVERSA (ERDAFITINIB) — FDA approval
erdafitinib
→
Nov 22, 2019
approval
TREMFYA (GUSELKUMAB) — FDA approval
guselkumab
→
Nov 7, 2019
approval
STELARA (USTEKINUMAB) — FDA approval
ustekinumab
→
Oct 18, 2019
approval
STELARA (USTEKINUMAB) — FDA approval
ustekinumab
→
Sep 24, 2019
approval
SIMPONI (GOLIMUMAB) — FDA approval
Janssen Biotech Inc
→
Sep 17, 2019
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Apr 12, 2019
approval
BALVERSA (ERDAFITINIB) — FDA approval
erdafitinib
→
Apr 4, 2019
approval
TREMFYA (GUSELKUMAB) — FDA approval
guselkumab
→
Jan 29, 2019
approval
TREMFYA (GUSELKUMAB) — FDA approval
guselkumab
→
Mar 6, 2018
approval
SIMPONI (GOLIMUMAB) — FDA approval
Janssen Biotech Inc
→
Feb 14, 2018
approval
ERLEADA (APALUTAMIDE) — FDA approval
apalutamide
→
Feb 9, 2018
approval
SIMPONI (GOLIMUMAB) — FDA approval
Janssen Biotech Inc
→
Nov 13, 2017
approval
SIMPONI (GOLIMUMAB) — FDA approval
Janssen Biotech Inc
→
Jul 13, 2017
approval
TREMFYA (GUSELKUMAB) — FDA approval
guselkumab
→
Jun 22, 2017
approval
SIMPONI (GOLIMUMAB) — FDA approval
Janssen Biotech Inc
→
Jan 30, 2017
approval
SIMPONI (GOLIMUMAB) — FDA approval
Janssen Biotech Inc
→
Sep 23, 2016
approval
STELARA (USTEKINUMAB) — FDA approval
ustekinumab
→
Jan 8, 2016
approval
SIMPONI (GOLIMUMAB) — FDA approval
Janssen Biotech Inc
→